Market Cap 1.60B
Revenue (ttm) 465.31M
Net Income (ttm) -44.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9.61%
Debt to Equity Ratio 0.14
Volume 968,000
Avg Vol 594,720
Day's Range N/A - N/A
Shares Out 49.51M
Stochastic %K 61%
Beta 1.59
Analysts Strong Sell
Price Target $49.89

Company Profile

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias;...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 513 755 4100
Fax: 513 755 4567
Address:
7555 Innovation Way, Mason, United States
KCclean
KCclean Jun. 4 at 11:36 AM
$ATRC crappy phone chart but I like this long setup against MA cluster and break of downtrend. 35.65 resistance near term a spot to watch
0 · Reply
JarvisFlow
JarvisFlow Apr. 30 at 2:21 PM
UBS has adjusted their stance on AtriCure ( $ATRC ), setting the rating to Buy with a target price of 60 → 58.
0 · Reply
JarvisFlow
JarvisFlow Apr. 30 at 11:00 AM
Needham has adjusted their stance on AtriCure ( $ATRC ), setting the rating to Buy with a target price of 51 → 44.
0 · Reply
JarvisFlow
JarvisFlow Apr. 2 at 3:05 PM
Citizens Capital Markets updates rating for AtriCure ( $ATRC ) to Market Outperform, target set at 60.
0 · Reply
ajmrtxl
ajmrtxl Apr. 1 at 3:41 PM
$ATRC's latest data on SqueezeFinder
0 · Reply
anachartanalyst
anachartanalyst Mar. 28 at 7:02 PM
$ATRC https://anachart.com/wp-content/uploads/ana_temp/1743188534_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Mar. 28 at 11:30 AM
Canaccord Genuity has updated their rating for AtriCure ( $ATRC ) to Buy with a price target of 52.
0 · Reply
JarvisFlow
JarvisFlow Mar. 27 at 2:23 PM
JP Morgan has updated their rating for AtriCure ( $ATRC ) to Overweight with a price target of 46.
0 · Reply
TraderTimes
TraderTimes Mar. 27 at 1:36 PM
Today's top five analyst targets https://t.co/Nf9Wt9msvk $MREO $CHWY $ATRC $AUR
0 · Reply
JarvisFlow
JarvisFlow Mar. 27 at 11:30 AM
Needham has updated their rating for AtriCure ( $ATRC ) to Buy with a price target of 51.
0 · Reply
Latest News on ATRC
AtriCure, Inc. (ATRC) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 9:34 PM EDT - 2 months ago

AtriCure, Inc. (ATRC) Q1 2025 Earnings Call Transcript


AtriCure Reports First Quarter 2025 Financial Results

Apr 29, 2025, 4:01 PM EDT - 2 months ago

AtriCure Reports First Quarter 2025 Financial Results


AtriCure Announces First Use of the AtriClip PRO-Mini® Device

Apr 10, 2025, 8:00 AM EDT - 2 months ago

AtriCure Announces First Use of the AtriClip PRO-Mini® Device


AtriCure to Announce First Quarter 2025 Financial Results

Apr 8, 2025, 8:00 AM EDT - 2 months ago

AtriCure to Announce First Quarter 2025 Financial Results


AtriCure to Host Analyst & Investor Day on March 26, 2025

Mar 12, 2025, 8:00 AM EDT - 3 months ago

AtriCure to Host Analyst & Investor Day on March 26, 2025


AtriCure, Inc. (ATRC) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 10:46 PM EST - 4 months ago

AtriCure, Inc. (ATRC) Q4 2024 Earnings Call Transcript


AtriCure, Inc. (ATRC) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 11:53 PM EDT - 8 months ago

AtriCure, Inc. (ATRC) Q3 2024 Earnings Call Transcript


AtriCure Reports Third Quarter 2024 Financial Results

Oct 29, 2024, 4:01 PM EDT - 8 months ago

AtriCure Reports Third Quarter 2024 Financial Results


AtriCure to Participate in the UBS Global Healthcare Conference

Oct 28, 2024, 8:00 AM EDT - 8 months ago

AtriCure to Participate in the UBS Global Healthcare Conference


AtriCure to Announce Third Quarter 2024 Financial Results

Oct 8, 2024, 8:00 AM EDT - 9 months ago

AtriCure to Announce Third Quarter 2024 Financial Results


AtriCure Receives CE-Mark for the EnCompass® Clamp

Oct 1, 2024, 8:00 AM EDT - 9 months ago

AtriCure Receives CE-Mark for the EnCompass® Clamp


AtriCure, Inc. (ATRC) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 12:01 AM EDT - 11 months ago

AtriCure, Inc. (ATRC) Q2 2024 Earnings Call Transcript


AtriCure Reports Second Quarter 2024 Financial Results

Jul 30, 2024, 4:01 PM EDT - 11 months ago

AtriCure Reports Second Quarter 2024 Financial Results


AtriCure to Announce Second Quarter 2024 Financial Results

Jul 9, 2024, 8:00 AM EDT - 1 year ago

AtriCure to Announce Second Quarter 2024 Financial Results


AtriCure, Inc. (ATRC) Q1 2024 Earnings Call Transcript

May 2, 2024, 1:48 AM EDT - 1 year ago

AtriCure, Inc. (ATRC) Q1 2024 Earnings Call Transcript


AtriCure Reports First Quarter 2024 Financial Results

May 1, 2024, 4:01 PM EDT - 1 year ago

AtriCure Reports First Quarter 2024 Financial Results


AtriCure to Announce First Quarter 2024 Financial Results

Apr 10, 2024, 8:00 AM EDT - 1 year ago

AtriCure to Announce First Quarter 2024 Financial Results


AtriCure, Inc. (ATRC) Q4 2023 Earnings Call Transcript

Feb 15, 2024, 10:30 PM EST - 1 year ago

AtriCure, Inc. (ATRC) Q4 2023 Earnings Call Transcript


AtriCure Appoints Shlomi Nachman to the Board of Directors

Jan 4, 2024, 8:00 AM EST - 1 year ago

AtriCure Appoints Shlomi Nachman to the Board of Directors


Buying These 4 Hated Names Devastated By The GLP-1 Hype

Nov 26, 2023, 10:07 PM EST - 1 year ago

Buying These 4 Hated Names Devastated By The GLP-1 Hype

DXCM MDT SWAV


AtriCure Releases 2023 ESG Report

Nov 14, 2023, 8:00 AM EST - 1 year ago

AtriCure Releases 2023 ESG Report


AtriCure: Appeal Lures For This Cure

Nov 10, 2023, 2:59 PM EST - 1 year ago

AtriCure: Appeal Lures For This Cure


AtriCure, Inc. (ATRC) Q3 2023 Earnings Call Transcript

Nov 1, 2023, 10:58 PM EDT - 1 year ago

AtriCure, Inc. (ATRC) Q3 2023 Earnings Call Transcript


AtriCure Reports Third Quarter 2023 Financial Results

Nov 1, 2023, 4:01 PM EDT - 1 year ago

AtriCure Reports Third Quarter 2023 Financial Results


AtriCure to Announce Third Quarter 2023 Financial Results

Oct 11, 2023, 8:00 AM EDT - 1 year ago

AtriCure to Announce Third Quarter 2023 Financial Results


AtriCure, Inc. (ATRC) Q2 2023 Earnings Call Transcript

Jul 25, 2023, 7:40 PM EDT - 2 years ago

AtriCure, Inc. (ATRC) Q2 2023 Earnings Call Transcript


KCclean
KCclean Jun. 4 at 11:36 AM
$ATRC crappy phone chart but I like this long setup against MA cluster and break of downtrend. 35.65 resistance near term a spot to watch
0 · Reply
JarvisFlow
JarvisFlow Apr. 30 at 2:21 PM
UBS has adjusted their stance on AtriCure ( $ATRC ), setting the rating to Buy with a target price of 60 → 58.
0 · Reply
JarvisFlow
JarvisFlow Apr. 30 at 11:00 AM
Needham has adjusted their stance on AtriCure ( $ATRC ), setting the rating to Buy with a target price of 51 → 44.
0 · Reply
JarvisFlow
JarvisFlow Apr. 2 at 3:05 PM
Citizens Capital Markets updates rating for AtriCure ( $ATRC ) to Market Outperform, target set at 60.
0 · Reply
ajmrtxl
ajmrtxl Apr. 1 at 3:41 PM
$ATRC's latest data on SqueezeFinder
0 · Reply
anachartanalyst
anachartanalyst Mar. 28 at 7:02 PM
$ATRC https://anachart.com/wp-content/uploads/ana_temp/1743188534_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Mar. 28 at 11:30 AM
Canaccord Genuity has updated their rating for AtriCure ( $ATRC ) to Buy with a price target of 52.
0 · Reply
JarvisFlow
JarvisFlow Mar. 27 at 2:23 PM
JP Morgan has updated their rating for AtriCure ( $ATRC ) to Overweight with a price target of 46.
0 · Reply
TraderTimes
TraderTimes Mar. 27 at 1:36 PM
Today's top five analyst targets https://t.co/Nf9Wt9msvk $MREO $CHWY $ATRC $AUR
0 · Reply
JarvisFlow
JarvisFlow Mar. 27 at 11:30 AM
Needham has updated their rating for AtriCure ( $ATRC ) to Buy with a price target of 51.
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 22 at 6:17 AM
$ATRC Digging the cardiac tech play. Strong product lineup and international growth potential. Might initiate a small position in ATRC. Watching closely. great article: https://beyondspx.com/article/atricure-inc-nasdaq-atrc-a-leader-in-cardiac-surgical-treatments-poised-for-continued-growth
0 · Reply
JarvisFlow
JarvisFlow Mar. 21 at 11:00 AM
Needham has adjusted their stance on AtriCure ( $ATRC ), setting the rating to Buy with a target price of 51.
0 · Reply
Theflash88
Theflash88 Mar. 18 at 11:35 AM
$ALT Folks .. also check out $ATRC ! Popped yesterday on huge volume.
0 · Reply
swingingtech
swingingtech Mar. 12 at 11:55 AM
$ESML $ATRC $RXRX $CLOV https://wallstreetwaves.com/analysts-predict-32-growth-potential-for-esml-holdings/
0 · Reply
d_risk
d_risk Feb. 15 at 4:31 PM
$ATRC - AtriCure Inc. Common Stock - 10K - Updated Risk Factors Expanded risks include AI misuse, broader FDA approval needs, off-label use concerns, patent disputes, and international cost containment, while specifics on compliance and operational risks are significantly reduced. #Risk https://d-risk.ai/ATRC/10-K/2025-02-14
0 · Reply
RockyTSTH
RockyTSTH Feb. 12 at 9:02 PM
$ATRC AtriCure Q4 2024 Adj. EPS $(0.08) Beats $(0.23) Estimate, Sales $124.300M Beat $121.842M Estimate
0 · Reply
Brando77
Brando77 Jan. 31 at 1:22 PM
$ATRC I have adopted a more aggressive investment strategy. I continue to make limited investments in some medical device companies that I believe have promising future development. I firmly believe in value investing and will focus on investing in fields I am familiar with. I have worked in the healthcare field for many years and have some basic understanding of it. I will invest in medical companies that I personally believe have great potential. This is undoubtedly a high-risk investment. These companies may have an EPS of just a few cents or even losses, but they should have good market prospects, unique technological advantages, and be companies whose potential has not yet been fully realized. If I am optimistic about them, I will invest some funds to support these companies, with the total amount not exceeding 3% of my investment portfolio.
0 · Reply
IN0V8
IN0V8 Jan. 23 at 3:48 PM
$ATRC Opportunity Needham raises target price to $51 from $40
1 · Reply
satsandstocks
satsandstocks Jan. 19 at 5:30 AM
$ATRC - Weekly
0 · Reply
rollinstone
rollinstone Jan. 17 at 5:30 PM
$ATRC measured move is to 58 from here. Lock and load.
0 · Reply
Theflash88
Theflash88 Jan. 15 at 6:58 PM
$ATRC C’mon EW!!!
0 · Reply